Bad medicine: the way we manage diabetes

Type 2 diabetes is a modern plague largely brought on by lifestyle and is considered a progressive, non-reversible condition. The polypharmacy of chronic disease is the drug industry’s lottery win, and no more so than in diabetes, with new drugs and the increasing use of analogue insulin in type 2 diabetes worth tens of billions of pounds worldwide.1 ⇑

The drug industry’s business plan for diabetes follows a familiar pattern:

• (1) Conduct questionable research and control the original data.

• (2) Schmooze the politicians, health regulators, and patient groups to suggest undertreatment and need for “urgent action.”

• (3) Recruit tame diabetologists, massage …